Table 3 Association between ApoE polymorphism, rs3810950 polymorphism and Alzheimer’s disease

E3/E3 GG

–

1.16

–

–

E3/E3 GA

1.09

1.42

1.22 (0.87–1.7)

0.2354

E3/E3 AA

1.54

4.83

4.16 (1.68–10.28)

0.0010

E3/E4 GG

1.52

4.55

3.92 (2.49–6.18)

< 0.0001

E3/E4 GA

1.33

2.51

2.16 (1.45–3.22)

0.0002

E3/E4 AA

1.43

3.29

2.84 (1.19–6.8)

0.0202

E4/E4 GG

1.35

2.67

2.3 (0.88–6.02)

0.1202

E4/E4 GA

1.54

5

4.31 (0.93–19.97)

0.0726

E4/E4 AA

1.63

7

6.03 (0.73–49.55)

0.0759

E2/E2 GG

1.39

3

2.59 (0.27–25.15)

0.6275

E2/E3 GG

0.87

0.9

0.78 (0.44–1.38)

0.3865

E2/E3 GA

0.76

0.7

0.6 (0.31–1.18)

0.1752

E2/E3 AA

1.19

1.8

1.55 (0.51–4.72)

0.5865

E2/E4 GG

1.43

3.33

2.87 (1.12–7.32)

0.0242

E2/E4 GA

1.41

3.25

2.8 (0.89–8.76)

0.0814

E1/E2 GG

1.24

2

1.72 (0.15–19.15)

1

E1/E4 GG

1.85

Inf

Inf

1